Cite
Jiménez-Vargas NN, Yu Y, Jensen DD, et al. Agonist that activates the µ-opioid receptor in acidified microenvironments inhibits colitis pain without side effects. Gut. 2021;doi: 10.1136/gutjnl-2021-324070.
Jiménez-Vargas, N. N., Yu, Y., Jensen, D. D., Bok, D. D., Wisdom, M., Latorre, R., Lopez, C., Jaramillo-Polanco, J. O., Degro, C., Guzman-Rodriguez, M., Tsang, Q., Snow, Z., Schmidt, B. L., Reed, D. E., Lomax, A. E., Margolis, K. G., Stein, C., Bunnett, N. W., & Vanner, S. J. (2021). Agonist that activates the µ-opioid receptor in acidified microenvironments inhibits colitis pain without side effects. Gut, . https://doi.org/10.1136/gutjnl-2021-324070
Jiménez-Vargas, Nestor Nivardo, et al. "Agonist that activates the µ-opioid receptor in acidified microenvironments inhibits colitis pain without side effects." Gut vol. (2021). doi: https://doi.org/10.1136/gutjnl-2021-324070
Jiménez-Vargas NN, Yu Y, Jensen DD, Bok DD, Wisdom M, Latorre R, Lopez C, Jaramillo-Polanco JO, Degro C, Guzman-Rodriguez M, Tsang Q, Snow Z, Schmidt BL, Reed DE, Lomax AE, Margolis KG, Stein C, Bunnett NW, Vanner SJ. Agonist that activates the µ-opioid receptor in acidified microenvironments inhibits colitis pain without side effects. Gut. 2021 Mar 30; doi: 10.1136/gutjnl-2021-324070. Epub 2021 Mar 30. PMID: 33785555; PMCID: PMC8608554.
Copy
Download .nbib